Feldan Bio Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Apr 2036
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Oct 28, 2027The maintenance fee for Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same (US 10,633,421) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,738,687 | Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same In force · From the USPTO record | In force | From the USPTO record | |
| US 10,633,421 | Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same In force · From the USPTO record | In force | From the USPTO record | |
| US 9,982,267 | Rationally-Designed Synthetic Peptide Shuttle Agents for Delivering Polypeptide Cargos from an Extracellular Space to the Cytosol And/Or Nucleus of a Target Eukaryotic Cell, Uses Thereof, Methods and Kits Relating to Same In force · High confidence | In force | High confidence | |
| US 11,629,170 | Rationally-Designed Synthetic Peptide Shuttle Agents for Delivering Polypeptide Cargos from an Extracellular Space to the Cytosol And/Or Nucleus of a Target Eukaryotic Cell, Uses Thereof, Methods and Kits Relating to Same In force · High confidence | In force | High confidence | |
| US 12,286,632 | Rationally-Designed Synthetic Peptide Shuttle Agents for Delivering Polypeptide Cargos from an Extracellular Space to the Cytosol And/Or Nucleus of a Target Eukaryotic Cell, Uses Thereof, Methods and Kits Relating to Same In force · High confidence | In force | High confidence | |
| US 12,060,387 | Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same In force · From the USPTO record | In force | From the USPTO record | |
| US 12,428,447 | Peptide-Based Non-Proteinaceous Cargo Delivery In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending